Open Access2-(fluorine-18)-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography after breast conserving surgery: Correlation with molecular markers of breast cancer
Author(s) -
Salih Özgüven,
Sabahat İnanır,
Halil Turgut Turoğlu,
Tanju Yusuf Erdıl,
Mustafa Ümit Uğurlu,
Bahadır M. Güllüoğlu
Publication year - 2016
Publication title -
indian journal of nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 13
eISSN - 0972-3919
pISSN - 0974-0244
DOI - 10.4103/0972-3919.181848
Subject(s) - medicine , breast cancer , positron emission tomography , estrogen receptor , progesterone receptor , immunohistochemistry , nuclear medicine , radiology , positron emission tomography computed tomography , pet ct , retrospective cohort study , cancer , oncology
To investigate the role of 2-(fluorine-18)-fluoro-2-deoxy-D-glucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) early after breast-conserving surgery (BCS) in patients with breast cancer (BC) and whether we can determine which molecular biomarkers of breast carcinoma put the patients at risk.